Elaine Darcy Por, MS, PhD

Affiliations: 
Pharmacology University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Pain signaling and Scaffolding
Google:
"Elaine Por"
Mean distance: 18.36 (cluster 32)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Por ED, Sandoval ML, Thomas-Benson C, et al. (2017) Repeat low-level blast exposure increases transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1) expression in the trigeminal ganglion. Plos One. 12: e0182102
Eskander MA, Ruparel S, Green DP, et al. (2015) Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8593-603
Rowan MP, Bierbower SM, Eskander MA, et al. (2014) Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk. Plos One. 9: e93688
Por ED, Gomez R, Akopian AN, et al. (2013) Phosphorylation regulates TRPV1 association with β-arrestin-2. The Biochemical Journal. 451: 101-9
Por ED, Bierbower SM, Berg KA, et al. (2012) β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel. The Journal of Biological Chemistry. 287: 37552-63
Jeske NA, Por ED, Belugin S, et al. (2011) A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphate. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8681-8
Gomez R, Por ED, Berg KA, et al. (2011) Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia. Pain. 152: 1548-54
Por ED, Samelson BK, Belugin S, et al. (2010) PP2B/calcineurin-mediated desensitization of TRPV1 does not require AKAP150. The Biochemical Journal. 432: 549-56
See more...